Cargando…
Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3
Numerous studies have highlighted the implications of the glycogen synthase kinase 3 (GSK-3) in several processes associated with Alzheimer’s disease (AD). Therefore, GSK-3 has become a crucial therapeutic target for the treatment of this neurodegenerative disorder. Hereby, we report the design and...
Autores principales: | Sciú, M. Lourdes, Sebastián-Pérez, Victor, Martinez-Gonzalez, Loreto, Benitez, Rocio, Perez, Daniel I., Pérez, Concepción, Campillo, Nuria E., Martinez, Ana, Moyano, E. Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211276/ https://www.ncbi.nlm.nih.gov/pubmed/30362380 http://dx.doi.org/10.1080/14756366.2018.1530223 |
Ejemplares similares
-
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Glycogen Synthase Kinase 3 Inhibitors in the Next Horizon for Alzheimer's Disease Treatment
por: Martinez, Ana, et al.
Publicado: (2011) -
The natural pyrazolotriazine pseudoiodinine from Pseudomonas mosselii 923 inhibits plant bacterial and fungal pathogens
por: Yang, Ruihuan, et al.
Publicado: (2023) -
Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3
por: Pardo, Marta, et al.
Publicado: (2015) -
Phylogenetic diversification of glycogen synthase kinase 3/SHAGGY-like kinase genes in plants
por: Yoo, Mi-Jeong, et al.
Publicado: (2006)